| Date | Time | Source | Headline | Symbol | Company |
| 03/23/2015 | 9:16AM | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:PCYC | (MM) |
| 03/23/2015 | 8:22AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PCYC | (MM) |
| 03/23/2015 | 8:08AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:PCYC | (MM) |
| 03/23/2015 | 8:02AM | The Motley Fool | Better Dividend Stock: AbbVie or Gilead Sciences, Inc.? | NASDAQ:PCYC | (MM) |
| 03/22/2015 | 8:01AM | The Motley Fool | Confessions of a Value Investor Stuck in a High-Growth Industry | NASDAQ:PCYC | (MM) |
| 03/19/2015 | 9:00AM | PR Newswire (US) | New ibrutinib (IMBRUVICA®) Data to be Presented at American Association for Cancer Research (AACR) Meeting | NASDAQ:PCYC | (MM) |
| 03/18/2015 | 1:27PM | Business Wire | PHARMACYCLICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout | NASDAQ:PCYC | (MM) |
| 03/17/2015 | 7:02AM | The Motley Fool | 3 Stocks Benefiting From Jaw-Dropping Growth in Specialty Drug Spending | NASDAQ:PCYC | (MM) |
| 03/17/2015 | 6:02AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PCYC | (MM) |
| 03/16/2015 | 4:43PM | Dow Jones News | Pharmacyclics: Imbruvica Shows Benefits in Study | NASDAQ:PCYC | (MM) |
| 03/16/2015 | 4:40PM | Dow Jones News | Pharmacyclics: Imbruvica Shows Benefits in Lymphoma, Leukemia Study | NASDAQ:PCYC | (MM) |
| 03/16/2015 | 3:00PM | PR Newswire (US) | Independent Data Monitoring Committee Unanimously Recommends Unblinding of IMBRUVICA® (ibrutinib) Phase III Combination HELI... | NASDAQ:PCYC | (MM) |
| 03/13/2015 | 6:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PCYC | (MM) |
| 03/13/2015 | 5:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PCYC | (MM) |
| 03/12/2015 | 7:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PCYC | (MM) |
| 03/10/2015 | 11:17AM | PR Newswire (US) | Pharmacyclics Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover | NASDAQ:PCYC | (MM) |
| 03/09/2015 | 4:56PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:PCYC | (MM) |
| 03/09/2015 | 12:45PM | Business Wire | PHARMACYCLICS INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to AbbVie | NASDAQ:PCYC | (MM) |
| 03/09/2015 | 11:21AM | Business Wire | INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Pharmacyclics Inc. of Commencement of Class Action Investigati... | NASDAQ:PCYC | (MM) |
| 03/09/2015 | 10:55AM | PR Newswire (US) | Ryan & Maniskas, LLP Announces Investigation of Pharmacyclics Inc. | NASDAQ:PCYC | (MM) |
| 03/06/2015 | 6:56PM | PR Newswire (US) | SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Pharmacyclics, Inc. - PCYC | NASDAQ:PCYC | (MM) |
| 03/06/2015 | 5:17PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:PCYC | (MM) |
| 03/06/2015 | 5:07PM | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:PCYC | (MM) |
| 03/06/2015 | 5:05PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PCYC | (MM) |
| 03/06/2015 | 11:28AM | PR Newswire (US) | INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of PHARMACYCLICS INC. of Commencement of Class Action Investigati... | NASDAQ:PCYC | (MM) |
| 03/05/2015 | 8:05PM | Dow Jones News | Biotech Bidding War Yields Rich Price | NASDAQ:PCYC | (MM) |
| 03/05/2015 | 8:00PM | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Pharmacyclics, Inc. | NASDAQ:PCYC | (MM) |
| 03/05/2015 | 5:35PM | PR Newswire (US) | Pharmacyclics, Inc. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout | NASDAQ:PCYC | (MM) |
| 03/05/2015 | 5:21PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:PCYC | (MM) |
| 03/05/2015 | 5:21PM | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:PCYC | (MM) |